Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 20,575 | 11,758 | 8,467 | 4,316 | 3,688 |
| Depreciation Amortization | 4,772 | 4,525 | 4,002 | 3,320 | 1,294 |
| Income taxes - deferred | 2,206 | -10 | 1,990 | 1,954 | 1,736 |
| Accounts receivable | 2,411 | -4,271 | -2,998 | -3,717 | -1,698 |
| Accounts payable and accrued liabilities | 623 | -2,879 | -6,594 | 5,785 | 141 |
| Other Working Capital | -2,921 | -9,473 | -6,962 | -3,776 | -4,903 |
| Other Operating Activity | -2,501 | 10,900 | 12,268 | -29 | 2,838 |
| Operating Cash Flow | $25,165 | $10,549 | $10,173 | $7,854 | $3,095 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -253 | -1,505 | -1,400 | -2,785 | -3,962 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -16,256 |
| Other Investing Activity | 0 | 0 | 0 | 105 | 0 |
| Investing Cash Flow | $-253 | $-1,505 | $-1,400 | $-2,680 | $-20,218 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -9,600 | -1,600 | -1,600 | -1,600 | -1,600 |
| Common Stock Issued | 3,054 | 389 | 161 | 197 | 3 |
| Other Financing Activity | 857 | 452 | 274 | 66 | -47 |
| Financing Cash Flow | $-5,689 | $-759 | $-1,165 | $-1,337 | $-1,644 |
| Exchange Rate Effect | 43 | 5 | -32 | -62 | 0 |
| Beginning Cash Position | 44,067 | 35,777 | 28,202 | 24,427 | 43,194 |
| End Cash Position | 63,333 | 44,068 | 35,777 | 28,202 | 24,427 |
| Net Cash Flow | $19,266 | $8,290 | $7,575 | $3,775 | $-18,767 |
| Free Cash Flow | |||||
| Operating Cash Flow | 25,165 | 10,549 | 10,173 | 7,854 | 3,095 |
| Capital Expenditure | -441 | -1,505 | -1,400 | -2,785 | -3,962 |
| Free Cash Flow | 24,724 | 9,044 | 8,773 | 5,069 | -868 |